The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Strategies to manage renal AA amyloidosis and advances in this space
Peter Kvacskay
• 6 Sep 2022
In this video, Peter Kvacskay, MD, Heidelberg University Hospital, Heidelberg, Germany, shares some insights into strategies used to manage patients with renal AA amyloidosis, including interleukin-1 blocking agents such as anakinra and canakinumab, and renal transplantation. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
